影响儿童免疫复原后异构性HSCT的因素:个性化疫苗接种方法的案例
Hélène Buvelot1, Frederic Baleydier2,3, Laure Pittet4
1Centre for Vaccinology, Geneva University Hospital, Geneva, Switzerland.
European journal of haematology
|December 18, 2025
概括
同源干细胞移植患者需要个性化疫苗接种计划. 诸如GVHD和淋巴细胞计数之类的因素,而不仅仅是时间,应指导再接种疫苗,以更好地预防疫苗可预防的疾病.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 移植医学 移植医学
背景情况:
- 全基性造血干细胞移植 (HSCT) 是各种疾病的关键治疗方法.
- 后HSCT患者因免疫抑制而面临疫苗可预防疾病 (VPD) 的脆弱性增加.
- 目前对HSCT接种者的疫苗接种指南是统一的,不考虑个体免疫恢复的变化.
研究的目的:
- 审查影响免疫复合和Allogeneic HSCT后疫苗反应的因素.
- 倡导个性化疫苗接种策略,而不是固定时间表.
- 探索针对CAR-T细胞等新兴免疫疗法的个性化疫苗接种.
主要方法:
- 在HSCT后影响免疫复合的因素的文献综述.
- 分析目前的疫苗接种指南及其局限性.
- 讨论针对个性化疫苗接种时间的免疫恢复标记.
主要成果:
- 免疫复制和疫苗反应受到调节方案,干细胞来源,HLA兼容性,GVHD和年龄的显著影响.
- 现有的统一疫苗接种计划可能不适合所有患者.
- 淋巴细胞计数和GVHD状态是调整疫苗接种时间的潜在标志物.
结论:
- 对所有原性HSCT患者来说,需要个性化的再接种方法.
- 接种疫苗的时间,特别是无活化疫苗,应以免疫恢复标志物为指导.
- 需要进一步的研究,特别是在儿童群体中,以建立个性化的疫苗接种方案.
更多相关视频
08:52Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
17.7K
10:24Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
Published on: October 5, 2015
12.8K
相关概念视频
Cell-mediated Immune Responses
83.3K
Overview
83.3K
Vaccinations
51.1K
Overview
51.1K
Immunodeficiency Diseases
1.9K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
1.9K
Development of Immunocompetence
771
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
771
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
